Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Harmony Biosciences Holdings Inc
(NQ:
HRMY
)
35.98
+0.23 (+0.64%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Aug 30, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Harmony Biosciences Holdings Inc
< Previous
1
2
3
4
5
6
Next >
Harmony Biosciences (HRMY) Q4 2022 Earnings Call Transcript
February 21, 2023
HRMY earnings call for the period ending December 31, 2022.
Via
The Motley Fool
Harmony Biosciences, The No. 3 Biotech, Just Topped Forecasts; But Concerns Persist
February 21, 2023
The company offered neither financial guidance nor plans for a new CEO.
Via
Investor's Business Daily
Big Retailers Report
February 21, 2023
Good Morning Everyone! Customers are setting banks on fire in Lebanon because they can’t get their money out. Inflation is at +170%. This is what a currency collapse looks like:
Via
Benzinga
Alkermes Stock Sees Rising Relative Price Strength
February 17, 2023
The Relative Strength (RS) Rating for Alkermes stock entered a new percentile Friday, with an increase from 79 to 86.
Via
Investor's Business Daily
Anavex Life Sciences Stock Shows Improved Price Strength Rating
February 07, 2023
Anavex Life Sciences stock saw a positive improvement to its Relative Strength (RS) Rating on Tuesday, rising from 68 to 75.
Via
Investor's Business Daily
With This Big Transition Ahead, Is Novavax a Buy?
January 12, 2023
Novavax stock sank 92% last year.
Via
The Motley Fool
4 Analysts Have This to Say About Harmony Biosciences
November 03, 2022
Within the last quarter, Harmony Biosciences (NASDAQ:HRMY) has observed the following analyst ratings:
Via
Benzinga
Where Harmony Biosciences Stands With Analysts
October 14, 2022
Analysts have provided the following ratings for Harmony Biosciences (NASDAQ:HRMY) within the last quarter:
Via
Benzinga
The 7 Best Biotech Stocks to Buy for February 2023
February 07, 2023
Following the wave of red ink last year, astute investors should target the best biotech stocks to buy this month for strong growth potential.
Via
InvestorPlace
7 Healthcare Stocks That Will Be Big Winners in 2023
January 31, 2023
Healthcare stocks had a strong 2022 which will continue throughout 2023 making these picks ones to consider.
Via
InvestorPlace
If You Invested $1,000 in Novavax In 2020, This Is How Much You Would Have Today
January 13, 2023
The stock has gone on a wild ride over the past few years.
Via
The Motley Fool
NVAX Stock Alert: What to Know as Novavax Names New CEO
January 09, 2023
Although a change at the top boosted sentiment for Novavax, the harsh reality is that NVAX stock faces a mountain of worries.
Via
InvestorPlace
Moderna Stock Shows Surprising Strength; Key Rating Upgraded
December 14, 2022
See if Moderna stock forms a new pattern or follow-on buying opportunity like a three-weeks tight or pullback to the 50-day average.
Via
Investor's Business Daily
6 Analysts Have This to Say About Harmony Biosciences
August 03, 2022
Harmony Biosciences (NASDAQ:HRMY) has observed the following analyst ratings within the last quarter:
Via
Benzinga
Why Cutera Shares Are Trading Lower By 23%? Here Are Other Stocks Moving In Monday's Mid-Day Session
January 09, 2023
Gainers CinCor Pharma, Inc. (NASDAQ: CINC) shares jumped 137% to $27.93 after AstraZeneca announced it will acquire the company for $26 per share in cash.
Via
Benzinga
BeiGene Stock Shows Market Leadership With Jump To 82 RS Rating
December 08, 2022
On Thursday, China-based BeiGene stock cleared that desired 80-plus benchmark, with a jump to 82 from 77 a day earlier.
Via
Investor's Business Daily
Xenon Pharmaceuticals Stock Scores Rising Relative Strength Upgrade
November 29, 2022
Xenon Pharmaceuticals stock had its Relative Strength (RS) Rating upgraded to 92 Tuesday, up from 89 a day earlier.
Via
Investor's Business Daily
BioCryst Pharmaceuticals Stock Sees RS Rating Rise To 84
November 11, 2022
The Relative Strength (RS) Rating for BioCryst Pharmaceuticals stock climbed into a new percentile Friday, with a rise from 64 to 84.
Via
Investor's Business Daily
Looking Into Harmony Biosciences's Return On Capital Employed
November 09, 2022
According to Benzinga Pro, during Q3, Harmony Biosciences (NASDAQ:HRMY) earned $87.94 million, a 273.73% increase from the preceding quarter. Harmony Biosciences also posted a total of $117.21 million...
Via
Benzinga
Why Harsco Shares Surged Over 22%; Here Are 80 Biggest Movers From Yesterday
November 02, 2022
Gainers
Via
Benzinga
Gartner, Sony, Uber And Other Big Gainers From Tuesday
November 02, 2022
U.S. stocks closed lower on Tuesday, with the Nasdaq Composite dropping around 100 points. Here is the list of some big stocks recording gains in the previous session.
Via
Benzinga
Harmony Biosciences Holdings, Inc. (HRMY) Q3 2022 Earnings Call Transcript
November 01, 2022
HRMY earnings call for the period ending September 30, 2022.
Via
The Motley Fool
Why IBD 50 Stock Harmony Biosciences Flew To The High End Of Its Buy Zone
November 01, 2022
The third-quarter beat, alone, wasn't enough to drive the positive stock movement.
Via
Investor's Business Daily
Recap: Harmony Biosciences Q3 Earnings
November 01, 2022
Harmony Biosciences (NASDAQ:HRMY) reported its Q3 earnings results on Tuesday, November 1, 2022 at 07:30 AM. Here's what investors need to know about the announcement. Earnings Harmony Biosciences...
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For October 14, 2022
October 14, 2022
Upgrades
Via
Benzinga
Domino's Pizza To Rally 20%? Here Are 5 Other Price Target Changes For Friday
October 14, 2022
Wedbush raised Domino's Pizza, Inc. (NYSE: DPZ) price target from $370 to $400. Wedbush analyst Nick Setyan maintained an Outperform rating on the stock. Domino's shares rose 10.4% to close at $333.26...
Via
Benzinga
Stock Market Rally Mixed As Oil Prices Fall, Job Growth Hot: Weekly Review
August 05, 2022
The Nasdaq and small caps rose while the S&P 500 is hitting resistance.
Via
Investor's Business Daily
Benzinga's Top Ratings Upgrades, Downgrades For August 3, 2022
August 03, 2022
Via
Benzinga
Harmony Biosciences Makes Leap Out Of Buy Zone After Narcolepsy Drug Drives Beat
August 02, 2022
Shares surged well above the 5% chase zone in early action Tuesday.
Via
Investor's Business Daily
Harmony Biosciences: Q2 Earnings Insights
August 02, 2022
Harmony Biosciences (NASDAQ:HRMY) reported its Q2 earnings results on Tuesday, August 2, 2022 at 07:30 AM. Here's what investors need to know about the announcement.
Via
Benzinga
< Previous
1
2
3
4
5
6
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.